‘Exhausting’ and ‘energizing’: First leader of high-risk medical research agency discusses startup | Science
Nine months after it was made by Congress, President Joe Biden’s new company for substantial-danger biomedical research has begun to...
Nine months after it was made by Congress, President Joe Biden’s new company for substantial-danger biomedical research has begun to...
SAN RAFAEL, Calif. & BARCELONA, December 07, 2022--(Small business WIRE)--IMIDomics, Inc., a biotechnology organization concentrated on the discovery and development...